Zhou HL - Search Results

1

Zhang D, Jian YP, Zhang YN, Li Y, Gu LT, Sun HH, Liu MD, Zhou HL, Wang YS, Xu ZX. Zhang D, et al. Among authors: zhou hl. Cell Commun Signal. 2023 Aug 18;21(1):212. doi: 10.1186/s12964-023-01219-9. Cell Commun Signal. 2023. PMID: 37596634 Free PMC article. Review.

2

The effect of erectile dysfunction on quality of life in male kidney transplant recipients.

Wang WG, Li P, Wang YS, Wang G, Wang YT, Zhou HL. Wang WG, et al. Among authors: zhou hl. Pak J Med Sci. 2014 Mar;30(2):361-5. Pak J Med Sci. 2014. PMID: 24772144 Free PMC article.

3

Effectiveness and safety of laparoscopic adrenalectomy of large pheochromocytoma: a prospective, nonrandomized, controlled study.

Wang W, Li P, Wang Y, Wang Y, Ma Z, Wang G, Gao J, Zhou H. Wang W, et al. Am J Surg. 2015 Aug;210(2):230-5. doi: 10.1016/j.amjsurg.2014.11.012. Epub 2015 Apr 4. Am J Surg. 2015. PMID: 25952614 Clinical Trial.

4

Fenofibrate Improved Interstitial Fibrosis of Renal Allograft through Inhibited Epithelial-Mesenchymal Transition Induced by Oxidative Stress.

Wang Y, Pang L, Zhang Y, Lin J, Zhou H. Wang Y, et al. Oxid Med Cell Longev. 2019 Feb 17;2019:8936856. doi: 10.1155/2019/8936856. eCollection 2019. Oxid Med Cell Longev. 2019. PMID: 30911353 Free PMC article.

5

Enhanced O-linked Glcnacylation in Crohn's disease promotes intestinal inflammation.

Sun QH, Wang YS, Liu G, Zhou HL, Jian YP, Liu MD, Zhang D, Ding Q, Zhao RX, Chen JF, Li YN, Liang J, Li YL, Quan CS, Xu ZX. Sun QH, et al. Among authors: zhou hl. EBioMedicine. 2020 Mar;53:102693. doi: 10.1016/j.ebiom.2020.102693. Epub 2020 Feb 27. EBioMedicine. 2020. PMID: 32114385 Free PMC article.

6

Profiles of tumor-infiltrating immune cells and prognostic genes associated with the microenvironment of bladder cancer.

Li F, Guo H, Wang Y, Liu B, Zhou H. Li F, et al. Int Immunopharmacol. 2020 Aug;85:106641. doi: 10.1016/j.intimp.2020.106641. Epub 2020 May 26. Int Immunopharmacol. 2020. PMID: 32470882

7

Upregulation of programmed death ligand 1 by liver kinase B1 and its implication in programmed death 1 blockade therapy in non-small cell lung cancer.

Shen X, Zhao Y, Liu G, Zhou HL, Fan J, Zhang L, Li YL, Wang Y, Liang J, Xu ZX. Shen X, et al. Among authors: zhou hl. Life Sci. 2020 Sep 1;256:117923. doi: 10.1016/j.lfs.2020.117923. Epub 2020 Jun 6. Life Sci. 2020. PMID: 32522567

8

Prognostic Value of Immune-Related Genes in the Tumor Microenvironment of Bladder Cancer.

Li F, Teng H, Liu M, Liu B, Zhang D, Xu Z, Wang Y, Zhou H. Li F, et al. Front Oncol. 2020 Jul 28;10:1302. doi: 10.3389/fonc.2020.01302. eCollection 2020. Front Oncol. 2020. PMID: 32850407 Free PMC article.

9

Explore prognostic biomarker of bladder cancer based on competing endogenous network.

Li F, Guo H, Liu B, Liu N, Xu Z, Wang Y, Zhou H. Li F, et al. Biosci Rep. 2020 Dec 23;40(12):BSR20202463. doi: 10.1042/BSR20202463. Biosci Rep. 2020. PMID: 33169791 Free PMC article.

10

LKB1 deficiency-induced metabolic reprogramming in tumorigenesis and non-neoplastic diseases.

Zhang Y, Meng Q, Sun Q, Xu ZX, Zhou H, Wang Y. Zhang Y, et al. Mol Metab. 2021 Feb;44:101131. doi: 10.1016/j.molmet.2020.101131. Epub 2020 Dec 3. Mol Metab. 2021. PMID: 33278637 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

346 results

Search Page